The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Which of the following represents a potential mechanism by which exercise may have neuroprotective effects?

  1. Reduced neuroinflammation.

  2. Upregulation of neurotrophic growth factors.

  3. Potentiation of remyelination.

  4. All of the above.

“Miguel” was 16 years old when he was referred to our clinic after social anxiety and depression evolved into signs of early psychosis. He had been in care for 2 years in private practice and was treated with various antidepressant medications and psychotherapy. During this time, he developed the perception that people strongly disliked him once they got to know him. He also heard his name called loudly from behind several times at school when no one was there. His community psychiatrist added risperidone, which suppressed the voices but led to lethargy and weight gain. A trial of aripiprazole was not effective, so he returned to taking risperidone along with escitalopram, gabapentin, and lorazepam. He was referred to our early psychosis program because of worsening symptoms and suicidal ideation despite this treatment.

On initial evaluation by our team, Miguel described extreme sadness and self-hatred associated with suicidal ideation. He was preoccupied with disliking his appearance, discomfort in social interactions, and feeling “stupid” in class relative to his peers despite receiving good grades. He feared impulsively acting on suicidal ideation. He reported that his friends at school could see and hear his thoughts when he was at home. He was sure that comments friends made at school confirmed that they knew his private thoughts. He also reported being watched in his room by schoolmates who wanted to catch him doing something embarrassing, and he had to position himself away from the window to avoid being monitored. He described intrusive fears of close family members being harmed or killed. He had a family history of schizophrenia in a second-degree and a third-degree relative. Miguel met the threshold for “severe and psychotic” on the Structured Interview for Psychosis-Risk Syndromes on two items (unusual thought content and suspiciousness/persecutory ideas) for less than 6 months, occurring at a frequency consistent with a psychotic episode. He was therefore given a diagnosis of schizophreniform disorder.

Miguel had been physically active in team sports throughout his school years. He had never experienced a concussion, and there was no head injury proximal to the onset of his symptoms. He had been inactive for months at the time of the initial interview because of lethargy and amotivation. The initial treatment plan included medication management, cognitive-behavioral therapy for psychosis, and lifestyle interventions, including regular physical exercise, a diet rich in fruits and vegetables, and supplementation with fish oil. Given the high level of acuity and risk, he was seen frequently by team members, with monitoring of lifestyle changes at every psychiatric visit. At the second visit, he reported feeling a sense of relief during a sports lesson, although his distress returned soon after the lesson ended. At that visit, his mother made a commitment to go walking with him daily. By the next session, he reported walking 1 hour daily, which he enjoyed and which led to improved mood and relaxation afterward. He continued daily exercise, including moderate-intensity weight training with a trainer at a gym for 30–60 minutes in addition to walking, with continued improvement in symptoms while engaged in physical activity. Both the patient and his family agreed that he felt his best during exercise, and his family committed to support him in regular participation.

Replacement of risperidone with lurasidone led to reduced side effects but no immediate improvement in psychotic symptoms, and a change to sertraline augmented with bupropion, buspirone, and trazodone was minimally helpful for his mood. Miguel remained intensely dysphoric and suicidal and felt hopeless about ever getting better, but he continued to report periods of respite after physical exercise. Over the next 6 months, the experience of thought broadcasting, monitoring, and family endangerment faded, but he described a disturbing buzzing feeling in his head and said he felt like part of his brain was missing. This evolved into a feeling of disconnection and perceptual distance from his environment and those around him.

He continued daily exercise with family support, and his periods of better mood began to lengthen. He also engaged in an alternative school setting with extensive individual support. While depersonalization persisted and was quite bothersome, all other psychotic symptoms resolved and suicidal ideation faded. Miguel expressed the concern that the medications were causing the buzzing feeling and interfering with his concentration. We therefore began a gradual process of tapering medications. By his eighth month in treatment, his regimen was simplified to sertraline, lurasidone, fish oil, and N-acetylcysteine, which was associated with some improvements in energy and concentration. After careful consideration of the risks and consequences of relapse, we proceeded to a careful taper of lurasidone at Miguel’s request to assess its impact on his feeling of impaired brain function. By the ninth month, lurasidone was discontinued, with some further improvement in energy and concentration, no change in the severity of depersonalization, and no return of psychotic symptoms or suicidal ideation.

Around this time, Miguel increased the intensity of his exercise regimen, with family support, including hour-long high-intensity swimming sessions 4 days per week with his father, interspersed with moderate-intensity weight training for 30–60 minutes and moderate-intensity hiking for 30–90 minutes with his mother or siblings on the remaining days. Miguel reported improved cognition in response to exercise, and he was able to return to a mainstream school setting. He strategically timed his physical exercise to occur between school and homework to achieve benefit for academic performance. Miguel’s family noticed gains, including a peaceful composure, a sense of relief, and genuine happiness. Close monitoring of symptoms during both psychiatric and psychotherapy visits revealed no evidence of a return of psychosis, and the experience of disconnection became somewhat more tolerable. He noted that focus on the technical aspects of a sport and being in nature during hikes were helpful in enabling him to feel more connected to his surroundings. By the 14th month, he successfully completed a term in school, remained in remission from psychosis and suicidal ideation, reported varying levels of anxiety in response to life stressors, and was making plans to continue his education.

Onset of psychosis is believed to be associated with neuronal dysregulation and degeneration. Reductions in brain volumes have been related in part to neuronal loss but more substantially to loss of neuronal connectivity, loss of dendritic spines, and reductions in supporting glial cells. These changes have been associated with alterations in neurotrophic factors in the brain. Recent evidence suggests that aggressive synaptic pruning may underlie onset of psychosis for some individuals (1). While reductions in regional brain volumes have been demonstrated in individuals in their first episode of schizophrenia, further deterioration has been shown to occur even after initiation of treatment (2, 3). The disruption of myelination has been proposed as one mechanism underlying these effects (4, 5). Duration of untreated psychosis is associated with both symptom severity and poor functional outcomes (6). Therefore, the time around onset of psychosis is considered a critical period when neuronal systems in the brain are vulnerable to deterioration, fragile, unstable, and in need of protection and, possibly, regeneration.

Several neuroprotective strategies have been attempted for people experiencing early stages of psychosis. One study demonstrated that for individuals at clinical high risk, omega-3 fatty acids appeared to reduce the risk of developing schizophreniform disorder (7, 8). However, results from other omega-3 trials for prevention and treatment of schizophrenia have not demonstrated consistent results (9). N-acetylcysteine supplementation as an adjuvant to antipsychotics has demonstrated reductions in total and negative symptoms in patients with schizophrenia, possibly because of its ability to reduce oxidative neuronal damage (10, 11).

Antipsychotic medication has been postulated to be neuroprotective regarding myelination and through modulation of brain-derived neurotrophic factor (BDNF). Antipsychotic treatment is associated with improvement in psychosis and completion of myelination if used consistently (4). Interestingly, it has been hypothesized that medications that target remyelination, such as those used for multiple sclerosis, may have certain advantages over antipsychotics in patients with schizophrenia (5). Another mechanism thought to add neuroprotection by antipsychotic treatment is through up-regulation of BDNF. However, the BDNF-inducing effects that antipsychotics potentiate appear to decrease over time (12), and there is some evidence of longitudinal gray matter volume changes (13). Antipsychotic treatment has also been associated with cardiometabolic dysregulation, overriding the genetic linkage between schizophrenia and anthropomorphic markers of thinness (14). People in early psychosis are particularly sensitive to these effects and may benefit from using exercise to maintain physical fitness and prevent weight gain and insulin, glucose, and lipid dysregulation (15, 16).

Neuroplastic and Neurogenic Effects of Physical Exercise

It is remarkable that exercise affects the same neuroprotective factors that are thought to be targeted by neutraceutical and antipsychotic medications. Exercise decreases neuroinflammation, up-regulates neurotrophic growth factors, potentiates remyelination, and appears to protect against age-related cognitive decline (17). It was first noticed in cohort studies that sedentary adults developed significantly more cognitive impairment and dementia than physically active adults (18).

It was later found that exercise increases systemic BDNF, which freely passes through the blood-brain barrier into the CNS, where it stimulates neurogenesis and synaptic plasticity (19). In landmark MRI studies evaluating the effects of exercise on the human brain, Colcombe and colleagues (20) discovered significant increases in white and gray matter tracts, thereby demonstrating that exercise can increase myelination and neurogenesis. A follow-up study by Erickson and colleagues (21) demonstrated that aerobic exercise could reverse the physical damage of age-related cognitive decline and increase hippocampal volume. Additional studies have since demonstrated that the territories of the brain that are most protected and regenerated by exercise are the frontal and hippocampal-temporal regions, which are centers of executive function, memory, and cognition (19) and are specific targets for neuroprotection in schizophrenia.

Firth and colleagues (22) examined 10 trials (total N=385) that specifically tested the impact of exercise on cognitive function in patients with schizophrenia. Exercise significantly improved global cognition, working memory, social cognition, and attention/vigilance. However, there were nonsignificant changes in processing speed, verbal and visual memory, and reasoning and problem solving. Subgroup analysis suggested that higher doses of exercise led to larger improvements.

Firth and colleagues further investigated trials that included evaluations of the mechanisms that exercise affects in patients with schizophrenia (23). Through examining imaging studies, Firth et al. found that exercise significantly improved brain volume in all but one small study, which was consistent with the effects of exercise found in other populations (21, 24). Through analysis of systemic biomarkers that correlate with neuroprotection and regeneration, four of five studies that examined serum BDNF found increases related to exercise, although significance was limited to two studies because of small samples in the other two (N=13 and N=4).

Despite the potential physical and mental health benefits of exercise, people with schizophrenia generally engage in very low levels of physical activity and have high levels of sedentary behavior, which has been associated with poorer cognitive performance (2527).

Physical Exercise in Early Psychosis

There is limited evidence on the impact of exercise in the prodromal and early phases of schizophrenia. In a study of ultra high-risk youths, Mittal and colleagues (28) demonstrated a significant association between meeting ultra high-risk criteria and having a sedentary lifestyle or engaging in markedly less light and vigorous activity, and an association that fell short of significance for those engaging in less moderate activity. The youths also had significantly smaller hippocampal volumes and right parahippocampal volume than matched control subjects. McEwen and colleagues (29) demonstrated that low compared with high physical activity levels were associated with significantly smaller volumes of total, prefrontal cortical, and hippocampal gray matter as well as of cortical thickness in the dorsolateral and orbitofrontal prefrontal cortex in 14 patients with first-episode schizophrenia. Sormunen and colleagues published findings (30) from the Cardiovascular Risk of Young Finns cohort study (N=3,596) demonstrating that inactivity was a strong independent risk factor for the development of schizophrenia. In a dose-dependent response, the lowest compared with the highest physical activity level was associated with a 3.87-fold higher risk of developing schizophrenia. Lack of participation in competitive sports, which provides both social support and physical activity, was associated with a 4.88-fold higher risk of developing schizophrenia.

Nuechterlein and colleagues (31) tested aerobic exercise plus cognitive training compared with cognitive training alone for a 10-week period for people in their first episode of schizophrenia. Their study design was inspired by animal models showing that combining aerobic exercise with learning tasks generated up to 30% more neurons than either intervention alone (32). Although this matched feasibility trial was too small to show significance (N=16), a large effect size was noted in social cognition, working memory, speed of processing, and attention/vigilance for the physical exercise group. Benefits were also observed for independent living, family network relationships, and working productivity, although these did not reach statistical significance.

Firth and colleagues also examined the benefits of 10 weeks of individualized exercise training for 38 patients with first-episode psychosis (33). This nonrandomized feasibility study found significantly greater improvement in the exercise group for total psychiatric symptoms (as measured by the Positive and Negative Syndrome Scale), negative symptoms, psychosocial functioning, and verbal short-term memory. Furthermore, a qualitative study of the same sample investigated how patients themselves subjectively experienced the exercise sessions (34). The findings support those of our own case study, with the majority of participants reporting acute mental health benefits during and immediately after engaging in moderate to vigorous physical activity.

Mittal and colleagues (35) conducted an exercise feasibility trial for sedentary youths at ultra high risk for developing schizophrenia. Nine of 12 recruited participants completed the 12-week trial with moderate to vigorous exercise 2 to 3 days per week. There were medium to large effect sizes for decreasing positive symptoms, small to medium effect sizes for decreasing negative symptoms, and improvements in social and role functioning and cognition. These changes were matched by increasing connectivity between the left hippocampus and the left and right occipital cortices. However, no change in hippocampal volume was noted. Mittal and colleagues are currently reexamining these results in a phase 2 clinical trial.

Lastly, McEwen and colleagues (36) conducted a randomized controlled trial in 37 patients with early schizophrenia. Patients were randomly assigned to either cognitive training alone or cognitive training plus aerobic exercise for 6 months. Cortical thickness significantly improved in the exercise group and was associated with improved reasoning, problem solving, global social functioning, global role functioning, verbal learning, and working memory. Cortical thickness decreased in the cognitive-training-alone group during the same period.

Behavioral Change Strategies

While approaches to assisting people with psychotic disorders with initiating and maintaining active physical exercise vary across studies and have not been directly compared, the following approach represents a composite of commonly used techniques, adapted to the clinical practice setting.

The first step is to carefully assess exercise participation, both lifetime and current, as part of initial evaluation (Figure 1). This communicates the importance of prioritizing physical exercise in medical care while also providing a basis for making exercise recommendations. After an assessment of the presenting problem and the contribution of the patient’s lifestyle, educate the patient about the role of physical exercise as a treatment option for his or her disorder. Inquire what types of exercise the patient prefers, as engaging in a type of exercise that the individual finds enjoyable will be the most likely to be sustainable over the long term. It is also important that the type of exercise be accessible (for example, if the patient enjoys swimming, confirm access to a pool; if the patient likes to bike outdoors, check whether or not he or she has access to a bicycle and safe places to ride). If patients do not have experience or preferences with regard to exercise, try to assist them in finding suitable options that are available to them. It is also important to consider safety when recommending an exercise program.

FIGURE 1.

FIGURE 1. Steps for Incorporating Physical Exercise in the Treatment of Patients With Psychiatric Disorders, With Exercise Recommendations and Elements of Response Assessment

As the treatment plan is developed with the patient, make clear recommendations if the patient chooses to include an exercise intervention in his or her plan. These recommendations should consider the patient’s current physical and mental capacity as well as target goals for treatment of his or her disorder based on the available evidence. Be specific about the type, duration, frequency, and intensity of the exercise that is ultimately recommended (Figure 1). Help the patient map out a weekly exercise schedule and set realistic goals. A good approach to helping the patient set goals can be framed using the acronym SMART—specific, measurable, attainable, realistic, and timely. Encourage the patient to use a behavioral monitoring tool, such as a training log or a wearable device, and to track health parameters such as weight, diet, medication adherence, sleep, and mood in the same log. Assess the patient’s adherence to the exercise plan at each follow-up visit, similar to assessing adherence to other treatment modalities (Figure 1). If the patient has not adhered to the plan, consider barriers and assist the patient in refining the plan to achieve greater success (37). Motivational supports such as exercising in a group or class, establishing an exercise partner such as a friend or family member, training for an exercise event, and recommended readings or videos may assist patients who are struggling to achieve adherence to their exercise plan. For patients who are resistant to inclusion of exercise in their care regimen, motivational interviewing techniques may help the patient consider behavior change related to increased activity (38).

During the monitoring process, it is important to highlight any success the patient has had with engaging in exercise. Engaging the patient in assessing outcomes of exercise may support long-term change. Carefully assess the patient’s experience during and after the exercise activity (39). Help the patient and family recognize how exercise may have changed the way the patient felt (better mood and energy, clearer thinking, enhanced self-esteem, improved body image, etc.) and how long it lasted (34). This will support growing connections between exercising and feeling better that can motivate further activity (37). At the end of the review, develop a shared decision for exercise goals for the coming interval to be reviewed at the next session. Always give generous recognition for the success the individual has achieved and assist him or her in viewing it as a process of growth. This iterative process of medical recommendation, close monitoring, and reinforcement of success was highly effective in supporting our patient in attaining a high level of regular physical exercise. Several studies also identify better adherence and improved outcomes when a trained fitness professional is incorporated to deliver the fitness intervention, which our patient also found valuable (40).

Conclusions

Individuals with psychotic disorders may benefit from establishing an exercise regimen as part of their care. Exercise effects neuroprotective mechanisms, such as decreasing inflammation, increasing neurogenesis and neuroplasticity, and remyelination of white matter tracts, resulting in at least a partial reversal of the regional brain matter loss that is seen in patients with psychosis. Clinically, there is substantial evidence that physical exercise can result in improvements in cognition, mood, and positive and negative symptoms. Further research is needed to assess optimal dose and type of exercise, motivational strategies, and potential impact on self-efficacy, reward, and social engagement. Initial evidence suggests that exercise may also have promise in early psychosis. It remains unknown whether exercise, in combination with other evidence-based interventions, might reduce the rate of conversion from attenuated psychosis syndrome or schizophreniform disorder to schizophrenia.

Remission from early psychosis in the context of evidence-based coordinated specialty care is not entirely unexpected, independent of exercise. However, the patient described in our case rapidly achieved high levels of physical exercise in response to specific lifestyle recommendations and a behavioral reinforcement process in our early psychosis program that may have contributed to his good outcome. While serial imaging and serum BDNF levels were not available for our patient, he did identify improvements in motivation, mood, and cognitive function and a return to his previous level of social and academic functioning in response to treatment that incorporated regular physical exercise. This is the first report of remission of psychosis that we are aware of in which vigorous physical exercise may have been a factor, and it is not the only such case we have seen.

Whether for the purpose of improving general health or the possibility of improving clinical symptoms, it would be beneficial for health care providers to assess physical activity and educate patients about exercise as a treatment option. Integrating exercise as a core component of early psychosis treatment for those who wish to undertake it has a range of potential benefits for mental and physical health, including potential synergies with other treatment components (41). Coordinated specialty care teams might incorporate a fitness instructor or link with a local fitness program to facilitate physical exercise, as implemented by the “In SHAPE” program (40, 42). It is important to make specific recommendations for exercise and support and monitor adherence when patients choose exercise as part of their care. Knowledge of the evidence supporting the efficacy of exercise in psychiatric disorders and the principles of behavioral change outlined here will help clinicians to be effective in the use of exercise in clinical care.

D. All of the above.

Want more? A CME course is available in the APA Learning Center ateducation.psychiatry.org

From the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, Calif.
Address correspondence to Dr. Noordsy ().

Dr. Noordsy has received research grants from Alkermes, Janssen, and NIDA. Dr. Ballon has received research funding from Alkermes and Otsuka America Pharmaceutical and has served on a subject matter expert panel for Pear Therapeutics. The other authors report no financial relationships with commercial interests.

References

1 Sekar A, Bialas AR, de Rivera H, et al.: Schizophrenia risk from complex variation of complement component 4. Nature 2016; 530:177–183Crossref, MedlineGoogle Scholar

2 Lieberman J, Chakos M, Wu H, et al.: Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 2001; 49:487–499Crossref, MedlineGoogle Scholar

3 Dempster K, Norman R, Théberge J, et al.: Cognitive performance is associated with gray matter decline in first-episode psychosis. Psychiatry Res 2017; 264:46–51Crossref, MedlineGoogle Scholar

4 Bartzokis G: Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 2002; 27:672–683Crossref, MedlineGoogle Scholar

5 Whitford TJ, Ford JM, Mathalon DH, et al.: Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. Schizophr Bull 2012; 38:486–494Crossref, MedlineGoogle Scholar

6 Penttilä M, Jääskeläinen E, Hirvonen N, et al.: Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2014; 205:88–94Crossref, MedlineGoogle Scholar

7 Amminger GP, Schäfer MR, Papageorgiou K, et al.: Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67:146–154Crossref, MedlineGoogle Scholar

8 Amminger GP, Schäfer MR, Schlögelhofer M, et al.: Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study. Nat Commun 2015; 6:7934Crossref, MedlineGoogle Scholar

9 Bozzatello P, Brignolo E, De Grandi E, et al.: Supplementation with omega-3 fatty acids in psychiatric disorders: a review of literature data. J Clin Med 2016; 5:67CrossrefGoogle Scholar

10 Berk M, Copolov D, Dean O, et al.: N-acetyl cysteine as a glutathione precursor for schizophrenia: a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 2008; 64:361–368Crossref, MedlineGoogle Scholar

11 Farokhnia M, Azarkolah A, Adinehfar F, et al.: N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study. Clin Neuropharmacol 2013; 36:185–192Crossref, MedlineGoogle Scholar

12 Tan YL, Zhou DF, Cao LY, et al.: Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci Lett 2005; 382:27–32Crossref, MedlineGoogle Scholar

13 Fusar-Poli P, Smieskova R, Kempton MJ, et al.: Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev 2013; 37:1680–1691Crossref, MedlineGoogle Scholar

14 Duncan LE, Shen H, Ballon JS, et al.: Genetic correlation profile of schizophrenia mirrors epidemiological results and suggests link between polygenic and rare variant (22q11.2) cases of schizophrenia. Schizophr Bull (Epub ahead of print, Dec 27, 2017)Google Scholar

15 Galling B, Roldán A, Nielsen RE, et al.: Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis. JAMA Psychiatry 2016; 73:247–259Crossref, MedlineGoogle Scholar

16 Correll CU, Solmi M, Veronese N, et al.: Prevalence, incidence, and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 2017; 16:163–180Crossref, MedlineGoogle Scholar

17 Cotman CW, Berchtold NC, Christie L-A: Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007; 30:464–472Crossref, MedlineGoogle Scholar

18 Hamer M, Chida Y: Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med 2009; 39:3–11Crossref, MedlineGoogle Scholar

19 Chieffi S, Messina G, Villano I, et al.: Neuroprotective effects of physical activity: evidence from human and animal studies. Front Neurol 2017; 8:188Crossref, MedlineGoogle Scholar

20 Colcombe SJ, Erickson KI, Scalf PE, et al.: Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci 2006; 61:1166–1170Crossref, MedlineGoogle Scholar

21 Erickson KI, Voss MW, Prakash RS, et al.: Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011; 108:3017–3022Crossref, MedlineGoogle Scholar

22 Firth J, Stubbs B, Rosenbaum S, et al.: Aerobic exercise improves cognitive functioning in people with schizophrenia: a systematic review and meta-analysis. Schizophr Bull 2017; 43:546–556MedlineGoogle Scholar

23 Firth J, Cotter J, Carney R, et al.: The pro-cognitive mechanisms of physical exercise in people with schizophrenia. Br J Pharmacol 2017; 174:3161–3172Crossref, MedlineGoogle Scholar

24 Voss MW, Heo S, Prakash RS, et al.: The influence of aerobic fitness on cerebral white matter integrity and cognitive function in older adults: results of a one-year exercise intervention. Hum Brain Mapp 2013; 34:2972–2985Crossref, MedlineGoogle Scholar

25 Stubbs B, Williams J, Gaughran F, et al.: How sedentary are people with psychosis? A systematic review and meta-analysis. Schizophr Res 2016; 171:103–109Crossref, MedlineGoogle Scholar

26 Stubbs B, Firth J, Berry A, et al.: How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis, and meta-regression. Schizophr Res 2016; 176:431–440Crossref, MedlineGoogle Scholar

27 Stubbs B, Ku PW, Chung MS, et al.: Relationship between objectively measured sedentary behavior and cognitive performance in patients with schizophrenia vs controls. Schizophr Bull 2017; 43:566–574MedlineGoogle Scholar

28 Mittal VA, Gupta T, Orr JM, et al.: Physical activity level and medial temporal health in youth at ultra high-risk for psychosis. J Abnorm Psychol 2013; 122:1101–1110Crossref, MedlineGoogle Scholar

29 McEwen SC, Hardy A, Ellingson BM, et al.: Prefrontal and hippocampal brain volume deficits: role of low physical activity on brain plasticity in first-episode schizophrenia patients. J Int Neuropsychol Soc 2015; 21:868–879Crossref, MedlineGoogle Scholar

30 Sormunen E, Saarinen MM, Salokangas RKR, et al.: Effects of childhood and adolescence physical activity patterns on psychosis risk: a general population cohort study. NPJ Schizophr 2017; 3:5Google Scholar

31 Nuechterlein KH, Ventura J, McEwen SC, et al.: Enhancing cognitive training through aerobic exercise after a first schizophrenia episode: theoretical conception and pilot study. Schizophr Bull 2016; 42(suppl 1):S44–S52Crossref, MedlineGoogle Scholar

32 Fabel K, Wolf SA, Ehninger D, et al.: Additive effects of physical exercise and environmental enrichment on adult hippocampal neurogenesis in mice. Front Neurosci 2009; 3:50MedlineGoogle Scholar

33 Firth J, Carney R, Elliott R, et al.: Exercise as an intervention for first-episode psychosis: a feasibility study. Early Interv Psychiatry, March 14, 2016 (doi 10.1111/eip:12329)Google Scholar

34 Firth J, Carney R, Jerome L, et al.: The effects and determinants of exercise participation in first-episode psychosis: a qualitative study. BMC Psychiatry 2016; 16:36Crossref, MedlineGoogle Scholar

35 Mittal V, Dean D, Gupta T, et al.: Aerobic exercise intervention for clinical high-risk youth improves cognitive and hippocampal abnormalities. Schizophr Bull 2017; 43 (suppl 1):S168CrossrefGoogle Scholar

36 McEwen S, Jarrahi B: Effects of exercise and cognitive training on the prefrontal cortex in first-episode schizophrenia patients. Schizophr Bull 2017; 43 (suppl 1):S242CrossrefGoogle Scholar

37 Firth J, Rosenbaum S, Stubbs B, et al.: Motivating factors and barriers towards exercise in severe mental illness: a systematic review and meta-analysis. Psychol Med 2016; 46:2869–2881Crossref, MedlineGoogle Scholar

38 Beebe LH, Smith K, Burk R, et al.: Effect of a motivational group intervention upon exercise self efficacy and outcome expectations for exercise in schizophrenia spectrum disorders (SSDs). J Am Psychiatr Nurses Assoc 2010; 16:105–113Crossref, MedlineGoogle Scholar

39 Dahle DN, Noordsy DL: Spontaneously exercising patients with schizophrenia spectrum disorder. Presented at the 167th Annual Meeting of the American Psychiatric Association, Poster Abstracts, 2014, Resident and Medical Student Competition No 136, 54–55Google Scholar

40 Vancampfort D, Rosenbaum S, Schuch FB, et al.: Prevalence and predictors of treatment dropout from physical activity interventions in schizophrenia: a meta-analysis. Gen Hosp Psychiatry 2016; 39:15–23Crossref, MedlineGoogle Scholar

41 Vancampfort D, De Hert M, Skjerven LH, et al.: International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia. Disabil Rehabil 2012; 34:1–12Crossref, MedlineGoogle Scholar

42 Naslund JA, Aschbrenner KA, Scherer EA, et al.: Health promotion for young adults with severe mental illness. Psychiatr Serv 2017; 68:137–143LinkGoogle Scholar